Stockreport

Novocure seeks approval after pancreatic cancer wearable scores at Phase III [Yahoo! Finance]

Zai Lab Limited - American Depositary Shares  (ZLAB) 
US:NASDAQ Investor Relations: zailaboratory.com/about/investors.php
PDF The PANOVA-3 study (NCT03377491) met its primary endpoint, improving overall survival (OS) for patients with unresectable, locally advanced pancreatic adenocarcinoma tr [Read more]